Brunmeir R, Ying L, Yan J, Hee Y, Lin B, Kaur H
Leukemia. 2025; 39(3):650-662.
PMID: 39774797
PMC: 11879851.
DOI: 10.1038/s41375-024-02509-y.
Mishra R, Thunuguntla P, Perkin A, Duraiyan D, Bagwill K, Gonzales S
bioRxiv. 2024; .
PMID: 38979159
PMC: 11230414.
DOI: 10.1101/2024.06.27.600975.
Blake D, Gazzara M, Breuer I, Ferretti M, Lynch K
Sci Rep. 2024; 14(1):10987.
PMID: 38745101
PMC: 11094061.
DOI: 10.1038/s41598-024-61951-1.
Gallicchio L, Olivares G, Berry C, Fuller M
RNA Biol. 2023; 20(1):908-925.
PMID: 37906624
PMC: 10730144.
DOI: 10.1080/15476286.2023.2275109.
Zhu W, Wheeler B, Ansel K
Trends Immunol. 2023; 44(10):792-806.
PMID: 37599172
PMC: 10890840.
DOI: 10.1016/j.it.2023.07.006.
Extension of mRNA poly(A) tails and 3'UTRs during neuronal differentiation exhibits variable association with post-transcriptional dynamics.
Kiltschewskij D, Harrison P, Fitzsimmons C, Beilharz T, Cairns M
Nucleic Acids Res. 2023; 51(15):8181-8198.
PMID: 37293985
PMC: 10450200.
DOI: 10.1093/nar/gkad499.
Farnesyl diphosphate synthase promotes cell proliferation by regulating gene expression and alternative splicing profiles in HeLa cells.
Wang L, Chen Z, Chen D, Kan B, He Y, Cai H
Oncol Lett. 2023; 25(4):145.
PMID: 36936029
PMC: 10018273.
DOI: 10.3892/ol.2023.13731.
Macrophage differentiation is marked by increased abundance of the mRNA 3' end processing machinery, altered poly(A) site usage, and sensitivity to the level of CstF64.
Mukherjee S, Graber J, Moore C
Front Immunol. 2023; 14:1091403.
PMID: 36761770
PMC: 9905730.
DOI: 10.3389/fimmu.2023.1091403.
Alternative polyadenylation regulation in cardiac development and cardiovascular disease.
Cao J, Kuyumcu-Martinez M
Cardiovasc Res. 2023; 119(6):1324-1335.
PMID: 36657944
PMC: 10262186.
DOI: 10.1093/cvr/cvad014.
The transcriptional terminator XRN2 and the RNA-binding protein Sam68 link alternative polyadenylation to cell cycle progression in prostate cancer.
Pieraccioli M, Caggiano C, Mignini L, Zhong C, Babini G, Lattanzio R
Nat Struct Mol Biol. 2022; 29(11):1101-1112.
PMID: 36344846
PMC: 9872553.
DOI: 10.1038/s41594-022-00853-0.
Context-specific regulation and function of mRNA alternative polyadenylation.
Mitschka S, Mayr C
Nat Rev Mol Cell Biol. 2022; 23(12):779-796.
PMID: 35798852
PMC: 9261900.
DOI: 10.1038/s41580-022-00507-5.
Enhancers regulate 3' end processing activity to control expression of alternative 3'UTR isoforms.
Kwon B, Fansler M, Patel N, Lee J, Ma W, Mayr C
Nat Commun. 2022; 13(1):2709.
PMID: 35581194
PMC: 9114392.
DOI: 10.1038/s41467-022-30525-y.
CELF Family Proteins in Cancer: Highlights on the RNA-Binding Protein/Noncoding RNA Regulatory Axis.
Nasiri-Aghdam M, Garcia-Garduno T, Jave-Suarez L
Int J Mol Sci. 2021; 22(20).
PMID: 34681716
PMC: 8537729.
DOI: 10.3390/ijms222011056.
The landscape of alternative polyadenylation in single cells of the developing mouse embryo.
Agarwal V, Lopez-Darwin S, Kelley D, Shendure J
Nat Commun. 2021; 12(1):5101.
PMID: 34429411
PMC: 8385098.
DOI: 10.1038/s41467-021-25388-8.
The three as: Alternative splicing, alternative polyadenylation and their impact on apoptosis in immune function.
Blake D, Lynch K
Immunol Rev. 2021; 304(1):30-50.
PMID: 34368964
PMC: 8616797.
DOI: 10.1111/imr.13018.
CELF2 is a candidate prognostic and immunotherapy biomarker in triple-negative breast cancer and lung squamous cell carcinoma: A pan-cancer analysis.
Wang L, Liu Z, Liu L, Guo C, Jiao D, Li L
J Cell Mol Med. 2021; 25(15):7559-7574.
PMID: 34288370
PMC: 8335674.
DOI: 10.1111/jcmm.16791.
Construction of Two Alternative Polyadenylation Signatures to Predict the Prognosis of Sarcoma Patients.
Hu C, Liu C, Li J, Yu T, Dong J, Chen B
Front Cell Dev Biol. 2021; 9:595331.
PMID: 34195183
PMC: 8236624.
DOI: 10.3389/fcell.2021.595331.
Genome-Wide Analyses of Prognostic and Therapeutic Alternative Splicing Signatures in Bladder Urothelial Carcinoma.
Fan Z, Zhang Z, Piao C, Liu Z, Wang Z, Kong C
Front Oncol. 2021; 11:626858.
PMID: 33842332
PMC: 8033158.
DOI: 10.3389/fonc.2021.626858.
ELAV/Hu RNA binding proteins determine multiple programs of neural alternative splicing.
Lee S, Wei L, Zhang B, Goering R, Majumdar S, Wen J
PLoS Genet. 2021; 17(4):e1009439.
PMID: 33826609
PMC: 8055025.
DOI: 10.1371/journal.pgen.1009439.
SRSF3 and SRSF7 modulate 3'UTR length through suppression or activation of proximal polyadenylation sites and regulation of CFIm levels.
Schwich O, Blumel N, Keller M, Wegener M, Setty S, Brunstein M
Genome Biol. 2021; 22(1):82.
PMID: 33706811
PMC: 7948361.
DOI: 10.1186/s13059-021-02298-y.